Literature DB >> 20440757

Entry kinetics and cell-cell transmission of surface-bound retroviral vector particles.

Lee S O'Neill1, Amy M Skinner, Josha A Woodward, Peter Kurre.   

Abstract

BACKGROUND: Transduction with recombinant HIV-1 derived lentivirus vectors is a multi-step process initiated by surface attachment and subsequent receptor-directed uptake into the target cell. We previously reported the retention of vesicular stomatitis virus G protein pseudotyped particles on murine progenitor cells and their delayed cell-cell transfer.
METHODS: To examine the underlying mechanism in more detail, we used a combination of approaches focused on investigating the role of receptor-independent factors in modulating attachment.
RESULTS: The investigation of synchronized transduction reveals cell-type specific rates of vector particle clearance with substantial delays during particle entry into murine hematopoietic progenitor cells. The observed uptake kinetics from the surface of the 1 degrees cell correlate inversely with the magnitude of transfer to 2 degrees targets, corresponding with our initial observation of preferential cell-cell transfer in the context of brief vector exposures. We further demonstrate that vector particle entry into cells is associated with the cell-type specific abundance of extracellular matrix fibronectin. Residual particle-extracellular fibronectin matrix binding and 2 degrees transfer can be competitively disrupted by heparin exposure without affecting murine progenitor homing and repopulation.
CONCLUSIONS: Although cellular attachment factors, including fibronectin, aid gene transfer by colocalizing particles to cells and disfavoring early dissociation from targets, they also appear to stabilize particles on the cell surface. The present study highlights the inadvertent consequences for cell entry and cell-cell transfer. Copyright (c) 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20440757      PMCID: PMC2864923          DOI: 10.1002/jgm.1458

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  57 in total

1.  Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression.

Authors:  Gregory Lizée; Joeri L Aerts; Monica I Gonzales; Nachimuthu Chinnasamy; Richard A Morgan; Suzanne L Topalian
Journal:  Hum Gene Ther       Date:  2003-04-10       Impact factor: 5.695

2.  Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment.

Authors:  Frederic Mazurier; Olga I Gan; Joby L McKenzie; Monica Doedens; John E Dick
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

3.  Enhancement and inhibition of avian sarcoma viruses by polycations and polyanions.

Authors:  K Toyoshima; P K Vogt
Journal:  Virology       Date:  1969-07       Impact factor: 3.616

4.  Retrovirus-associated heparan sulfate mediates immobilization and gene transfer on recombinant fibronectin.

Authors:  Pedro Lei; Bharat Bajaj; Stelios T Andreadis
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

5.  Kinetics and effect of integrin expression on human CD34(+) cells during murine leukemia virus-derived retroviral transduction with recombinant fibronectin for stem cell gene therapy.

Authors:  Yasuomi Horiuchi; Masafumi Onodera; Yoshitaka Miyagawa; Ban Sato; Keiko Onda; Yohko U Katagiri; Hajime Okita; Mayumi Okada; Makoto Otsu; Akihiro Kume; Torayuki Okuyama; Junichiro Fujimoto; Tadatoshi Kuratsuji; Nobutaka Kiyokawa
Journal:  Hum Gene Ther       Date:  2009-07       Impact factor: 5.695

6.  Heparin binds to murine leukemia virus and inhibits Env-independent attachment and infection.

Authors:  Simon J Walker; Massimo Pizzato; Yasuhiro Takeuchi; Stephen Devereux
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

7.  Charged polymers modulate retrovirus transduction via membrane charge neutralization and virus aggregation.

Authors:  Howard E Davis; Matthew Rosinski; Jeffrey R Morgan; Martin L Yarmush
Journal:  Biophys J       Date:  2004-02       Impact factor: 4.033

8.  FISH analysis of 142 EGFP transgene integration sites into the mouse genome.

Authors:  Tomoko Nakanishi; Asato Kuroiwa; Shuichi Yamada; Ayako Isotani; Atsuko Yamashita; Ai Tairaka; Tamon Hayashi; Tatsuya Takagi; Masahito Ikawa; Yoichi Matsuda; Masaru Okabe
Journal:  Genomics       Date:  2002-12       Impact factor: 5.736

9.  Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV.

Authors:  Rabia Sadir; Anne Imberty; Françoise Baleux; Hugues Lortat-Jacob
Journal:  J Biol Chem       Date:  2004-08-02       Impact factor: 5.157

10.  Visualization of the intracellular behavior of HIV in living cells.

Authors:  David McDonald; Marie A Vodicka; Ginger Lucero; Tatyana M Svitkina; Gary G Borisy; Michael Emerman; Thomas J Hope
Journal:  J Cell Biol       Date:  2002-11-04       Impact factor: 10.539

View more
  8 in total

Review 1.  Biosafety features of lentiviral vectors.

Authors:  Axel Schambach; Daniela Zychlinski; Birgitta Ehrnstroem; Christopher Baum
Journal:  Hum Gene Ther       Date:  2013-02       Impact factor: 5.695

2.  Shedding of clinical-grade lentiviral vectors is not detected in a gene therapy setting.

Authors:  M Cesani; T Plati; L Lorioli; F Benedicenti; D Redaelli; F Dionisio; L Biasco; E Montini; L Naldini; A Biffi
Journal:  Gene Ther       Date:  2015-03-12       Impact factor: 5.250

3.  Phenotypic correction of Fanconi anemia cells in the murine bone marrow after carrier cell mediated delivery of lentiviral vector.

Authors:  Santhosh Chakkaramakkil Verghese; Natalya A Goloviznina; Peter Kurre
Journal:  Stem Cell Res Ther       Date:  2016-11-19       Impact factor: 6.832

4.  Efficient CRISPR/Cas9 genome editing in a salmonid fish cell line using a lentivirus delivery system.

Authors:  Remi L Gratacap; Tim Regan; Carola E Dehler; Samuel A M Martin; Pierre Boudinot; Bertrand Collet; Ross D Houston
Journal:  BMC Biotechnol       Date:  2020-06-23       Impact factor: 2.563

5.  A Microfluidic Device to Enhance Viral Transduction Efficiency During Manufacture of Engineered Cellular Therapies.

Authors:  Nathan Moore; John R Chevillet; Laura J Healey; Connor McBrine; Daniel Doty; Jose Santos; Bryan Teece; James Truslow; Vienna Mott; Peter Hsi; Vishal Tandon; Jeffrey T Borenstein; Jenna Balestrini; Kenneth Kotz
Journal:  Sci Rep       Date:  2019-10-22       Impact factor: 4.379

6.  Cell-cell transmission of VSV-G pseudotyped lentivector particles.

Authors:  Amy M Skinner; Santhosh Chakkaramakkil Verghese; Peter Kurre
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

7.  Immunization with an SIV-based IDLV Expressing HIV-1 Env 1086 Clade C Elicits Durable Humoral and Cellular Responses in Rhesus Macaques.

Authors:  Donatella Negri; Maria Blasi; Celia LaBranche; Robert Parks; Harikrishnan Balachandran; Michelle Lifton; Xiaoying Shen; Thomas Denny; Guido Ferrari; Maria Fenicia Vescio; Hanne Andersen; David C Montefiori; Georgia D Tomaras; Hua-Xin Liao; Sampa Santra; Barton F Haynes; Mary E Klotman; Andrea Cara
Journal:  Mol Ther       Date:  2016-06-21       Impact factor: 11.454

8.  Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens.

Authors:  Alessandra Gallinaro; Martina Borghi; Roberta Bona; Felicia Grasso; Laura Calzoletti; Laura Palladino; Serena Cecchetti; Maria Fenicia Vescio; Daniele Macchia; Valeria Morante; Andrea Canitano; Nigel Temperton; Maria Rita Castrucci; Mirella Salvatore; Zuleika Michelini; Andrea Cara; Donatella Negri
Journal:  Front Immunol       Date:  2018-02-05       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.